Immunitybio Inc

NASDAQ IBRX

Data sourced from iex and EODHD
Download Data

Immunitybio Inc Cash Flow Statement 2014 - 2024

This table shows the Cash Flow Statement for Immunitybio Inc going from 2014 until 2024. The cash flow statement is a financial statement that shows the inflow and outflow of cash and cash equivalents from a company's operating, investing, and financing activities over a specified period. It provides crucial information about a company's ability to generate and manage cash, which is essential for its day-to-day operations, investments, and debt obligations.
Cash Flow Statement Trend Unit 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31
Net Income
M -134 -233 -96 -138 -117 -108 -111 -95 -103 -92 -88 -89 -80 -69 -66 -52 -37 -16 -16 -17 -18 -17 -24 -28 -28 -24 -24 -23 -25 -24 -32 -34 -31 -77 -43 -85 -33 -3
Depreciation and Amortization
M 5 5 5 5 5 5 5 4 4 4 4 4 3 2 4 3 3 2 2 2 3 3 3 2 2 2 1 1 1 2 1 1 0 0 0 1 0 0
Non-Cash Items (Other)
M 31 151 10 23 -11 10 4 11 4 13 4 4 5 5 14 2 3 13 12 9 -24 8 19 18 6 17 20 35 14 12 6 12 75 57 -236 -67 11 -57
Operating Cash Flow
M -107 -115 -87 -80 -84 -91 -81 -91 -75 -72 -73 -70 -60 -58 -37 -46 -31 -15 -17 -17 -13 -14 -18 -16 -16 -14 -10 -15 -10 -11 -11 -8 -9 -11 -4 -3 -7 -3
Capital Expenditures
M -1 -8 -6 -9 -8 -19 -16 -16 -49 -10 -8 -8 -7 -1 -2 0 0 -1 0 -1 -2 -2 -4 -2 -5 -11 -11 -8 -5 -1 -3 -1 -1 -1 -1 -1 0 0
Net Acquisitions
M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Other Investing Activities
M - - - - - - - - -21 - 20 - 39 -18 -25 30 14 - - - - - - - - - - - - - - - - - - - - -
Investing Cash Flow
M - - - - - - - - -21 - 20 - 39 -18 -25 30 14 - - - - - - - - - - - - - - - - - - - - -
Repayment/Issuance of Debt (Net)
M - - - 30 30 50 124 124 124 299 299 299 40 -4 - -4 -4 62 - - - - - - - - - - - - - - - - - - - -
Equity Repurchase (Common, Net)
M -4 -2 -1 0 0 0 - - 0 28 44 98 0 0 0 87 0 - - - 0 0 - - -3 -3 - -11 -1 -4 -3 -7 -3 - - - - -
Dividends Paid
M 0 - 1 0 0 0 - - - - - - - - - - - - - - - - - - - 1 - - - 1 - - - - - - - -
Other Financial Activities
M -4 384 200 30 30 50 124 0 0 298 1 98 38 -1 64 87 0 0 0 -1 39 0 0 0 0 0 0 0 1 0 0 0 1 0 -2 74 0 59
Financing Cash Flow
M -4 384 200 30 30 50 124 0 0 298 1 98 38 -1 64 87 0 0 0 -1 39 0 0 0 0 0 0 0 1 0 0 0 1 0 -2 74 0 59
Exchange Rate Adjustment
M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Beginning Cash
M 265 178 44 89 105 104 62 37 181 65 84 45 35 85 115 59 76 18 18 24 17 15 16 11 24 21 39 14 8 31 38 63 176 359 120 50 59 3
Ending Cash
M 133 265 178 44 89 105 104 62 37 181 65 84 45 35 85 115 59 16 18 18 24 17 15 16 11 24 21 39 14 8 31 38 63 176 359 120 50 59
Stock-Based Compensation
M 8 13 14 11 11 9 11 10 10 10 14 18 15 1 1 0 0 0 0 1 1 1 4 9 9 9 9 9 10 11 19 23 21 71 36 80 25 1
Issuance/Purchase of Shares
M -4 -2 -1 0 0 0 - - 0 28 44 98 0 0 0 87 0 - - - 0 0 - - -3 -3 - -11 -1 -4 -3 -7 -3 - - - - -
Capital Stock Change
M 0 9 40 14 47 60 0 - - 28 42 - - - - - - - - - - - - - - - - - - - - - - - - - - -
Working Capital
M 142 236 125 -547 -451 -360 72 -261 -169 -35 29 39 20 44 77 98 30 44 59 75 86 62 70 90 107 112 128 145 182 193 204 208 218 291 354 115 47 57
Free Cash Flow
M -108 -123 -93 -88 -93 -110 -97 -107 -124 -82 -81 -78 -68 -57 -39 -46 -31 -16 -17 -18 -15 -16 -21 -19 -20 -25 -21 -23 -15 -12 -14 -9 -10 -12 -5 -3 -7 -3

StockViz Staff

September 20, 2024

Any question? Send us an email